Stocks for Your Radar Screen
Four new watch lists.
Four new watch lists.
We periodically assemble lists of stocks we think are worth watching, and here are four of our latest lists:
These aren't buy lists. Most of these stocks aren't even cheap in our opinion. But fundamental to our way of thinking about stocks is this two-step process:
First, identify companies you're comfortable holding. For most prudent investors, that means focusing on companies possessing competitive advantages, or economic moats, which allow them to earn high returns on investors' capital. It also means focusing on companies that fit well into your portfolio; for example, if you've run your portfolio through our Diagnostics tool and found you lack exposure to a major segment of the market, you'll want to focus on strong companies in that area.
Secondly, monitor these stocks until they become cheap--for example, when they go from 1 or 2 stars to 4 or 5. Granted, some of these stocks may never become cheap, but market whims ensure that most of them will at some point. That's why it pays to create watch lists. It keeps us vigilant.
To create any of the four watch lists I named above, read on. A note for folks reading this on May 21: Today we're giving away a Portfolio Assessment Guide to anyone who creates a portfolio--including one of these watch lists--on Morningstar.com. It's part of our "Portfolio Day," when we offer all users of Morningtar.com access to our Portfolio tools, including all X-Ray views, Diagnostics, and Stock Intersection, which on any other day are part of our Premium Membership package. To learn more about portfolio day, click here.
How to Create a Watch List
To monitor the stocks on any of the watch lists I've broken out below, simply:
The whole process should take about 30 seconds.
Mid-Caps with Moats: Create This Watch List
In the June issue of Morningstar StockInvestor, editor Mark Sellers is debuting a new list of mid-cap companies with wide economic moats (another term for competitive advantages). These stocks aren't necessarily cheap--quality companies rarely are--but they're perfect for a watch list. That way you can watch for those rare occasions when they do trade at a discount to fair value.
I picked out 10 of the 25 companies on the StockInvestor list to create. Stocks included: Cedar Fair (FUN), Concord EFS , Danaher (DHR), Dow Jones , First Health , Gentex (GNTX), Intuit (INTU), Guidant , Expeditors International (EXPD), and Moody's (MCO).
Bargain Financials Stocks: Create This Watch List
We don't make sector calls at Morningstar, but we do think the financial sector harbors a good number of bargains right now. Pat Dorsey, Morningstar's director of stock analysis, just wrote a piece spotlighting four stocks--each with 4-star ratings--that our analysts like in this sector.
In this watch list of financials stocks, I've included the four in Pat's article, along with some financial stocks on the Bellwether 50 list in Morningstar StockInvestor. Stocks included: J.P. Morgan Chase (JPM), Citigroup (C), FleetBoston Financial , White Mountains Insurance (WTM), Merrill Lynch , American Express (AXP), Berkshire Hathaway (BRK.B), BlackRock (BLK), Fannie Mae (FNM), and Freddie Mac (FRE).
Interesting Health Stocks: Create This Watch List
Another sector in which you can find the stocks of good companies selling for cheap prices is health. As Pat Dorsey said in a recent column, "pipelines for a lot of large pharmaceutical companies are drying up, biotechs are getting crushed after overpromising and underdelivering for the umpteenth time, and everybody loves to hate HMOs."
I created this watch list from the health stocks our analysts currently like and those that have strong economic moats. Stocks included: Amgen (AMGN), Eli Lilly & Company (LLY), Pfizer (PFE), Johnson & Johnson (JNJ), Abbott Laboratories (ABT), Bristol-Myers Squibb (BMY), ICOS , First Health Group , and Waters (WAT).
Low-Risk, High-Yield Stocks: Create This Watch List
As a glance at our highest-rated stocks shows, it's not easy to find low-risk companies selling for cheap prices. Instead, it's the high-risk fare that the market is pushing to potentially bargain levels. To keep an eye out for low-risk stocks that drift into bargain territory, here's a list of stocks that receive a Low Risk rating from our analysts and which sport a dividend yield of at least 2%. These are the kind of companies that won't pull an Enron or Global Crossing and spiral into oblivion. And the high dividend yield means you're not relying just on a rising stock price to reap a return.
Stocks included: Aegon (AEG), Albertson's , Cadberry-Schweppes (CSG), Diageo (DEO), General Mills (GIS), GlaxoSmithKline (GSK), Kellogg (K), Merck (MRK), National City , Southern (SO), SunTrust Banks .
More Reading
Four Financial Stock Picks, by Pat Dorsey
Our Favorite Bank Stocks, by Craig Woker
Five Cheap Health Stocks, by Pat Dorsey
Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.
We’d like to share more about how we work and what drives our day-to-day business.
We sell different types of products and services to both investment professionals
and individual investors. These products and services are usually sold through
license agreements or subscriptions. Our investment management business generates
asset-based fees, which are calculated as a percentage of assets under management.
We also sell both admissions and sponsorship packages for our investment conferences
and advertising on our websites and newsletters.
How we use your information depends on the product and service that you use and your relationship with us. We may use it to:
To learn more about how we handle and protect your data, visit our privacy center.
Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.
To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.
Read our editorial policy to learn more about our process.